peoplePerson
Fei Ma
A breast oncologist who led Chinese pyrotinib and ADC trials and studies of ctDNA in HER2-positive disease.
Fei Ma has led trials of pyrotinib and HER2-directed antibody-drug conjugates in Chinese patients and research on circulating tumour DNA and resistance in HER2-positive breast cancer.
Role
Professor of Medical Oncology; Cancer Hospital, Chinese Academy of Medical Sciences
Specialisms
Breast cancerHER2Antibody-drug conjugatesCirculating tumour DNA